Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Clark

Showing results (1601-1610 of 1,669) with videos related to

Pageof 167
Sort By:
The Oncologist|May 10, 2013
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experienceJason E Faris, Lawrence S Blaszkowsky, Shaunagh McDermott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
ROS1 rearrangements define a unique molecular class of lung cancersKristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, et al.
The Oncologist|August 22, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric CancersSurendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal AdenocarcinomaHao Liu, Kamila Naxerova, Matthias Pinter, et al.
JCO Oncology Practice|May 27, 2021
Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal CancerKatie Kanter, Madeleine Fish, Gianluca Mauri, et al.
Hepatology Communications|September 18, 2021
Genome-Wide Association Study of NAFLD Using Electronic Health RecordsCameron J Fairfield, Thomas M Drake, Riinu Pius, et al.
The New England Journal of Medicine|September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Hepatology (Baltimore, Md.)|October 15, 2021
Genome-wide analysis identifies gallstone-susceptibility loci including genes regulating gastrointestinal motilityCameron J Fairfield, Thomas M Drake, Riinu Pius, et al.
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Annals of Surgery|January 20, 2015
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerCristina R Ferrone, Giovanni Marchegiani, Theodore S Hong, et al.
Pageof 167

Showing results (1601-1610 of 1,669) with videos related to

Sort By:
Pageof 167
The Oncologist|May 10, 2013
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experienceJason E Faris, Lawrence S Blaszkowsky, Shaunagh McDermott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
ROS1 rearrangements define a unique molecular class of lung cancersKristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, et al.
The Oncologist|August 22, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric CancersSurendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal AdenocarcinomaHao Liu, Kamila Naxerova, Matthias Pinter, et al.
JCO Oncology Practice|May 27, 2021
Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal CancerKatie Kanter, Madeleine Fish, Gianluca Mauri, et al.
Hepatology Communications|September 18, 2021
Genome-Wide Association Study of NAFLD Using Electronic Health RecordsCameron J Fairfield, Thomas M Drake, Riinu Pius, et al.
The New England Journal of Medicine|September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Hepatology (Baltimore, Md.)|October 15, 2021
Genome-wide analysis identifies gallstone-susceptibility loci including genes regulating gastrointestinal motilityCameron J Fairfield, Thomas M Drake, Riinu Pius, et al.
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Annals of Surgery|January 20, 2015
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerCristina R Ferrone, Giovanni Marchegiani, Theodore S Hong, et al.
Pageof 167